<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: In order to achieve optimal outcomes when treating ventricular tachyarrhythmias with implantable devices, it is extremely important to identify parameters predisposing to <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In view of current restrictions in healthcare funding, there is a growing demand for additional predictors of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> that would allow better patient selection for implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) use for primary prevention of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> (SCD) </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To identify parameters predisposing to ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> recipients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We analysed 376 patients (56 women, 320 men, mean age 66.1 ± 11.2 [range 22-89] years) who underwent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation between January 2008 and December 2010 </plain></SENT>
<SENT sid="4" pm="."><plain>Of these, 275 patients underwent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation for primary prevention of SCD and 101 for secondary prevention </plain></SENT>
<SENT sid="5" pm="."><plain>Operative protocols and in-hospital and outpatient records were analysed retrospectively </plain></SENT>
<SENT sid="6" pm="."><plain>Mean QRS width and heart rate (HR) were calculated in resting surface electrocardiograms (25 mm/s, 10 mm/1 mV) </plain></SENT>
<SENT sid="7" pm="."><plain>Intracardiac electrograms stored in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> memory were used to evaluate appropriateness of anti-arrhythmic interventions and analyse the number of ventricular tachyarrhythmia events, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions and their type </plain></SENT>
<SENT sid="8" pm="."><plain>We analysed the following clinical and procedural variables: age, gender, left ventricular ejection fraction (LVEF), type of SCD prevention (primary or secondary), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> type (single chamber--VR, dual chamber--DR), performing defibrillation threshold testing to establish defibrillation safety margin at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, ventricular lead location (right ventricular outflow tract region, right ventricular apex), mean HR, QRS width, New York Heart Association (NYHA) functional class, occurrence of ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention after implantation, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions, history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> (<z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, ischaemic and non-ischaemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo>, <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, <z:hpo ids='HP_0004754'>permanent atrial fibrillation</z:hpo>, percutaneous coronary intervention, and/or coronary artery bypass grafting), and medications (<z:chebi fb="0" ids="2663">amiodarone</z:chebi>, sotalol, beta-blockers, <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitors</z:chebi> [ACEI]/angiotensin receptor blockers [ARB], <z:chebi fb="0" ids="35664">statins</z:chebi>, loop <z:chebi fb="40" ids="35498">diuretics</z:chebi>, <z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi>) </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: During the mean follow-up period of 387 ± 300 (range 5-1400) days, appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention due to ventricular tachyarrhythmia occurred in 68 of 376 ICD patients (61 men, 7 women, mean age 64.7 ± 12.3 [range 22-89] years) </plain></SENT>
<SENT sid="10" pm="."><plain>Mean time interval from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation to the occurrence of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> was 281 ± 229 (range 5-972) days (p 〈 0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>To optimize sensitivity and specificity when analysing ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention vs. no ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention, cutoff values were established using ROC curves (cutoff for LVEF = 31%, HR = 79 bpm) </plain></SENT>
<SENT sid="12" pm="."><plain>Using these cutoff values, patients with ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention were compared to those without ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention </plain></SENT>
<SENT sid="13" pm="."><plain>Significant differences were observed in LVEF (p&lt; 0.001), HR (p&lt; 0.022), ACEI/ARB use (p&lt; 0.034), and NYHA class (p&lt; 0.001) </plain></SENT>
<SENT sid="14" pm="."><plain>By Kaplan-Meier univariate analysis, patients with LVEF&gt; 31% (log-rank test p&lt; 0.001), HR ≤ 79 bpm (log-rank test p&lt; 0.022), QRS width ≤ 114 ms (log-rank test p &lt; 0.045), and NYHA class II (log-rank test p&lt; 0.001) were more likely to be free from ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention </plain></SENT>
<SENT sid="15" pm="."><plain>Cox multivariate analysis showed that reduced LVEF (≤ 31%) was the only independent predictor of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>/intervention </plain></SENT>
<SENT sid="16" pm="."><plain>LVEF values below 31% are associated with a significant 20-fold increase (p&lt; 0.02) in the risk of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> during the first 3 years after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation </plain></SENT>
<SENT sid="17" pm="."><plain>Among 68 patients with ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention, mean 4.1 interventions per person occurred during the follow-up period </plain></SENT>
<SENT sid="18" pm="."><plain>In the overall study population, the number of interventions was 0.28 per person per year </plain></SENT>
<SENT sid="19" pm="."><plain>Overall, 92 inappropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions were observed, <z:hpo ids='HP_0000001'>all</z:hpo> resulting from <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> with rapid ventricular rate </plain></SENT>
<SENT sid="20" pm="."><plain>Interventions had no effect on total mortality </plain></SENT>
<SENT sid="21" pm="."><plain>Higher numbers of appropriate interventions were observed in patients who died due to <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="22" pm="."><plain>CONCLUSIONS: Factors associated with a significantly increased risk of ventricular tachyarrhythmia/appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> intervention included reduced LVEF, increased resting HR, NYHA class II or higher <z:hpo ids='HP_0001635'>heart failure</z:hpo>, and wide QRS </plain></SENT>
<SENT sid="23" pm="."><plain>Patients with low LVEF (&lt; 31%) are at particular risk of SCD due to <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> and this parameter alone can influence the decision regarding <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation </plain></SENT>
<SENT sid="24" pm="."><plain>No effect of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions on total mortality was observed, although more <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions were observed in patients who died due to <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
</text></document>